AU2002352221A1 - Bicyclic n-arylamides - Google Patents

Bicyclic n-arylamides

Info

Publication number
AU2002352221A1
AU2002352221A1 AU2002352221A AU2002352221A AU2002352221A1 AU 2002352221 A1 AU2002352221 A1 AU 2002352221A1 AU 2002352221 A AU2002352221 A AU 2002352221A AU 2002352221 A AU2002352221 A AU 2002352221A AU 2002352221 A1 AU2002352221 A1 AU 2002352221A1
Authority
AU
Australia
Prior art keywords
arylamides
bicyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002352221A
Other languages
English (en)
Inventor
Frank-Gerhard Boss
Christina Erb
Timo Flessner
Martin Hendrix
Joachim Luithle
Christoph Methfessel
Marja Van Kampen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2002352221A1 publication Critical patent/AU2002352221A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2002352221A 2001-12-19 2002-12-06 Bicyclic n-arylamides Abandoned AU2002352221A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10162375A DE10162375A1 (de) 2001-12-19 2001-12-19 Bicyclische N-Aryl-amide
DE10162375.5 2001-12-19
PCT/EP2002/013835 WO2003051874A1 (de) 2001-12-19 2002-12-06 Bicyclische n-arylamide

Publications (1)

Publication Number Publication Date
AU2002352221A1 true AU2002352221A1 (en) 2003-06-30

Family

ID=7709793

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002352221A Abandoned AU2002352221A1 (en) 2001-12-19 2002-12-06 Bicyclic n-arylamides

Country Status (8)

Country Link
US (1) US7247728B2 (enExample)
EP (1) EP1458716B1 (enExample)
JP (1) JP4690651B2 (enExample)
AU (1) AU2002352221A1 (enExample)
CA (1) CA2470726C (enExample)
DE (2) DE10162375A1 (enExample)
ES (1) ES2274114T3 (enExample)
WO (1) WO2003051874A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
GB0220581D0 (en) 2002-09-04 2002-10-09 Novartis Ag Organic Compound
CA2499128C (en) 2002-09-25 2012-07-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
US20040157626A1 (en) * 2003-02-10 2004-08-12 Vincent Park Paging methods and apparatus
US8196000B2 (en) * 2003-04-02 2012-06-05 Qualcomm Incorporated Methods and apparatus for interleaving in a block-coherent communication system
US7434145B2 (en) * 2003-04-02 2008-10-07 Qualcomm Incorporated Extracting soft information in a block-coherent communication system
DE10334724A1 (de) * 2003-07-30 2005-02-24 Bayer Healthcare Ag N-Biarylamide
PL1697378T3 (pl) 2003-12-22 2008-04-30 Memory Pharm Corp Indole, 1h-indazole, 1,2-benzoizoksazole i 1,2-benzoizotiazole oraz ich wytwarzanie i zastosowania
US7423164B2 (en) 2003-12-31 2008-09-09 Ut-Battelle, Llc Synthesis of ionic liquids
WO2005092890A2 (en) 2004-03-25 2005-10-06 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
DE602005024677D1 (de) 2004-04-22 2010-12-23 Memory Pharm Corp Indole, 1h-indazole, 1,2-benzisoxazole, 1,2-benzoisothiazole, deren herstellung und verwendungen
RU2386633C2 (ru) * 2004-05-07 2010-04-20 Мемори Фармасьютиклз Корпорейшн 1h-индазолы, бензотиазолы, 1, 2-бензоизоксазолы, 1, 2-бензоизотиазолы и хромоны и их получение и применения
PE20060437A1 (es) 2004-06-18 2006-06-08 Novartis Ag COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
GB0415746D0 (en) 2004-07-14 2004-08-18 Novartis Ag Organic compounds
JP2008525464A (ja) 2004-12-22 2008-07-17 メモリー・ファーマシューティカルズ・コーポレイション α−７ニコチン性受容体リガンド並びにその製造及び使用
CN101312968A (zh) * 2005-09-23 2008-11-26 记忆药物公司 吲唑、苯并噻唑、苯并异噻唑、苯并异噁唑、吡唑并吡啶、异噻唑并吡啶及其制备和用途
GB0521508D0 (en) 2005-10-21 2005-11-30 Novartis Ag Organic compounds
GB0525672D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
GB0525673D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
HUE026815T2 (en) 2008-11-19 2016-07-28 Forum Pharmaceuticals Inc Treatment of Cognitive Disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
AU2010247835A1 (en) * 2009-05-11 2011-12-08 Envivo Pharmaceuticals, Inc. Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors
TWI519532B (zh) 2010-05-17 2016-02-01 艾維沃製藥公司 （Ｒ）－７－氯－Ｎ－（啶－３－基）苯並［b］噻吩－２－羧醯胺鹽酸鹽單水合物之結晶形體
RU2017136693A (ru) 2012-05-08 2019-02-08 Форум Фармасьютикалз, Инк. Способы поддержания, лечения или улучшения когнитивной функции
CA2952188A1 (en) * 2014-06-20 2015-12-23 Aurigene Discovery Technologies Limited Substituted indazole compounds as irak4 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605652A (en) 1985-02-04 1986-08-12 A. H. Robins Company, Inc. Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
US5206235A (en) * 1991-03-20 1993-04-27 Merck & Co., Inc. Benzo-fused lactams that promote the release of growth hormone
SE0000540D0 (sv) * 2000-02-18 2000-02-18 Astrazeneca Ab New compounds
WO2002000653A2 (en) * 2000-06-28 2002-01-03 Bristol-Myers Squibb Company Fused cyclic compounds as modulators of nuclear hormone receptor function
DE20013068U1 (de) * 2000-07-27 2001-11-29 AUTEFA Automation GmbH, 86316 Friedberg Fördereinrichtung für Kannen in einem Kannenlager

Also Published As

Publication number Publication date
EP1458716A1 (de) 2004-09-22
CA2470726A1 (en) 2003-06-26
JP4690651B2 (ja) 2011-06-01
CA2470726C (en) 2012-01-31
US7247728B2 (en) 2007-07-24
DE10162375A1 (de) 2003-07-10
ES2274114T3 (es) 2007-05-16
US20050107460A1 (en) 2005-05-19
JP2005517657A (ja) 2005-06-16
DE50208287D1 (de) 2006-11-09
WO2003051874A1 (de) 2003-06-26
EP1458716B1 (de) 2006-09-27

Similar Documents

Publication Publication Date Title
AU2002313565A1 (en) Putter-heads
AU2002336311A1 (en) Bicyclic compound
AU2002308154A1 (en) Triazolopyrimidines
AU2002364901A1 (en) Object decontaminator
AU2002319532A1 (en) Feeding-bottles
AU2002330025A1 (en) Atlastin
AU2001100406A4 (en) DriverSMS
AU2002313943A1 (en) Electromobile
AU2002226571A1 (en) Biligands
AU2001100338A4 (en) Sunglove
AU2002100746A4 (en) Adrail
AU2001100214A4 (en) Dolly-trolley
AU2001100522A4 (en) e-Trans
AU2001100532A4 (en) FonePark
AU2002313073A1 (en) Phytocystatin
AU2001100129A4 (en) Easy-loader trailer
AU2002257925A1 (en) Numberplates
AU2002302546A1 (en) Fitting
AU2002304671A1 (en) Triazolopyrimidines
AU2002300980A1 (en) Insanityse
AU2002300330A1 (en) Spiralnet
AU2002300850A1 (en) Treeguard
AU2002357687A1 (en) Pyrazolopyrimidines
AU2002249693A1 (en) Starseparator
AU2002312695A1 (en) Mini-scooter

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase